Closing date: 09 Feb 2018
MiracleFeet is an international nonprofit organization that increases access to proper treatment for children born with clubfoot in developing countries through partnerships with local healthcare providers. There are over one million people living with untreated clubfoot around the world, making it one of the primary causes of physical disability in the world. Thanks to a non-surgical treatment known as the Ponseti Method, it is possible to treat clubfoot effectively and safely for as little as $250 per child. By increasing access to treatment, MiracleFeet gives children born with clubfoot the chance to live healthy, productive lives.
See www.miraclefeet.org to learn more about the issue of clubfoot.
MiracleFeet supports clubfoot programs in 22 countries which have treated over 29,000 children till date, and takes a business-minded approach to solving the problem of clubfoot. The MiracleFeet Foot Abduction Brace, designed in collaboration with Stanford University, helps brings low cost treatment to clinics around the world. In 2016, MiracleFeet won a $1 Million grant from Google.org to developed technology tools to assist the operation of clubfoot clinics – these tools are currently being tested and deployed around the world.
See https://www.miraclefeet.org/our-work/innovation/ for more on MiracleFeet’s approach to innovation.
MiracleFeet began working in India in 2011, and has supported the treatment of over 14,500 children till date. In 2014, MiracleFeet India was established in Mumbai with the vision of building a self-sustainable, Indian-led NGO focused on clubfoot. Since then, MiracleFeet India has gained the support of leading Indian corporations and foundations, including the JSW Foundation, Bajaj Foundation, Hero Enterprises, Tata Power, Tata Investment Corporation, Tata International, Videocon D2H, Pacific India, and more. The organization has recruited an all-Indian Board of Directors composed of business and medical leaders passionate about tackling the cause of clubfoot.
MiracleFeet India is officially registered as the “MiracleFeet Foundation for Eliminating Clubfoot” and is 12AA and 80G registered.
The Executive Director (ED) of MiracleFeet India is entrusted with realizing MiracleFeet’s mission of ensuring that no child grows up disabled as a result of being born with clubfoot.
The ED leads the organization in developing the programmatic model, financial resources, organizational infrastructure, culture, and competencies necessary to reach MiracleFeet India’s long-term goal of ending disability caused by clubfoot in India. The position demands a passion for building sustainable health programs which put the child at the center of decision making. The ED also needs an entrepreneurial spirit, flexibility, and energy to continue to grow and develop a young NGO.
Reporting to the India Board of Directors and working closely with MiracleFeet USA leadership, the Executive Director will have overall strategic and operational responsibility for MiracleFeet India’s staff, programs, resource mobilization, expansion, and execution of its mission. The ED will have deep knowledge of core programs, will have a full understanding of the fundraising and CSR landscape, and will ensure that the organization operates efficiently within the approved budget and in full compliance with Indian government regulations. He/she will develop and execute a 3-year operating plan, strategic goals and budget with input from the senior leadership team, to be reviewed and approved by the Board of Directors.
The Executive Director will be based in MiracleFeet’s Mumbai office and will travel frequently within India and occasionally internationally to support the fundraising and programmatic needs of the organization.
How to apply:
See this link for detailed job description: https://www.miraclefeet.org/wp-content/uploads/2018/01/MF-India-Executive-Director-Job-Description.pdf
Interested candidates may email a cover letter and CV to firstname.lastname@example.org. Applications will be accepted through Friday, February 9th.